KVDOS Bio

rewiring the code of life

Science

Therapeutic Pillars

Progenitor Cell Reactivation

Endogenous pathway modulation to engage quiescent tissue-resident cell populations — restoring regenerative signaling through intrinsic biological mechanisms.

Tissue Architecture & Repair

Targeted receptor engagement to accelerate native tissue remodeling cascades — supporting structural restoration through the body’s own repair biology.

Metabolic Reprogramming

Multi-axis modulation of cellular bioenergetics to reverse dormancy states in aged or senescent tissue — reengaging endogenous regenerative capacity.

Platform

Discovery Engine

Computational modeling integrated with predictive biology — accelerating candidate development from hypothesis through validation via a simulation-first discovery architecture.

› High-dimensional pharmacokinetic simulation with Bayesian parameter estimation

› Regulatory-aligned model verification and validation frameworks

› ML-driven target identification and binding affinity prediction

› Multi-pathway interaction modeling with sensitivity analysis

› Endpoint calibration against published clinical benchmarks

Model-Informed Development

Simulation-guided decision making embedded across the pipeline — from candidate selection through regulatory pathway planning. Computational confidence at every stage.

Pipeline & Programs

Advancing a proprietary portfolio of regenerative candidates through integrated computational discovery and formulation science.

OLV-006

Lipid Receptor Agonist

Hair & Follicle Biology Dormant Follicle Reactivation

OLV-006-WH

Receptor-Mediated ECM Axis

Chronic Wound Healing Tissue Closure & Matrix Remodeling

OLV-006-REGEN

Multi-Pathway Modulation

Tissue Regeneration Metabolic Reprogramming

Pre-Commercial Program

OLV-006-C Pre-Launch

Proprietary Formulation

Functional Wellness Topical Stem Cell Support

A distinct topical formulation advancing through CMC clearance under a separate regulatory and manufacturing pathway ahead of commercial introduction.

View Product →

Approach

Platform Architecture

Our candidates are developed through a simulation-first pipeline that integrates computational pharmacology, receptor-level target modeling, and advanced delivery system engineering. Each program undergoes multi-stage in silico validation — from pathway-level mechanism prediction through dose-response characterization — before advancing to biological confirmation.

Formulations are designed around structured carrier systems optimized for tissue-level bioavailability, enabling targeted engagement of endogenous regenerative pathways.